MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia with Lewy bodies (DLB)"

  • 2026 International Congress

    Latent Clinical States and Longitudinal Transitions in Prodromal Lewy Body Disease: A Data-Driven Analysis from the NaT-PROBE Study

    K. Fuse, K. Hiraga, Y. Yada, K. Nakao, Y. Saito, T. Fukushima, D. Tamakoshi, T. Uematsu, T. Tsuboi, M. Suzuki, M. Sato, M. Yamamoto, H. Shimizu, M. Wakai, N. Honda, M. Katsuno (Nagoya, Japan)

    Objective: To elucidate the structure of clinical heterogeneity and longitudinal transition patterns in a prodromal Lewy body disease (LBD) screening cohort using a data-driven approach.…
  • 2026 International Congress

    Human Snca Knock-In Mouse as a Model for Synucleinopathy Research

    E. Cinar, J. Ma, Y. Liang, K. Luk (Philadelphia, USA)

    Objective: Inter-species differences between mouse and human α-synuclein (asyn) may influence aggregation and pathology in animal models, highlighting the need for models expressing human asyn.…
  • 2026 International Congress

    Emergence of Cortical Amyloid from the Prodromal Stage of the Lewy Body Disease Spectrum: Evidence from a PiB-PET Study

    M. Yoshita, S. Tsuji, K. Yokoyama (Nanto, Japan)

    Objective: To characterize β-amyloid (Aβ) deposition across the Lewy body disease (LBD) spectrum using Pittsburgh compound B positron emission tomography (PiB-PET) and examine the influence…
  • 2026 International Congress

    Progressive Dynamic Functional Network Disorganisation and its Association with Phenoconversion in Isolated REM Sleep Behaviour Disorder: A Multicentre Study

    L. Churchill, J. Anderson, A. Ignatavicius, A. Konuri, M. Johansson, R. Gaurav, S. Lehéricy, S. Lewis, E. Matar (Sydney, Australia)

    Objective: To characterise static and dynamic functional connectivity signatures of disease progression and phenoconversion in a multicentre longitudinal cohort of individuals with isolated REM sleep…
  • 2026 International Congress

    Cholinergic Pathway Degeneration Predicts Differential Phenoconversion to Synucleinopathies in Idiopathic REM Sleep Behavior Disorder

    D. Zhang, T. Wu (Beijing, China)

    Objective: This cross-sectional and longitudinal study aimed to elucidate the pattern of cholinergic white matter pathway degeneration underlying the phenoconversion trajectories in iRBD patients. Background:…
  • 2026 International Congress

    Non-Rapid Eye Movement Sleep Neurophysiological Alterations in Lewy Body Disorders

    J. Anderson, L. Churchill, A. Konuri, A. Ignatavicius, G. Cho, A. Lam, S. Naismith, R. Grunstein, S. Lewis, E. Matar (Camperdown, Australia)

    Objective: To characterise NREM sleep neurophysiology across multiple domains in Lewy body disorders (LBDs) relative to healthy controls. Background: Sleep disturbances are highly prevalent in…
  • 2026 International Congress

    Remote Longitudinal Follow-up of Participants in the Parkinson’s Progression Markers Initiative (PPMI)

    C. Tanner, C. Meng, E. Brown, D. Paredes, P. Ranola, G. Windheim, E. Trinh, K. Comyns, J. Ricci, C. Destro, R. Tandon, K. Geisler, A. Siderowf, T. Simuni, K. Marek (San Francisco, USA)

    Objective: To assess a personalized protocol focused on maintaining contact for long-term follow-up of current and former clinical research participants Background: PPMI-FOUND enrolls participants at…
  • 2026 International Congress

    Prevalence and Clinical Determinants of Cognitive Impairment in a Diverse Parkinson’s Disease Cohort

    A. Zirra, K. Dey, E. Camboe, E. Bhadra, R. Laban, B. Huxford, S. Hussain-Ali, C. Simonet, C. Budu, D. Gallagher, S. Waters, V. Azoidou, T. Boyle, A. Lees, M. Perinan, C. Marshall, A. Noyce (London, United Kingdom)

    Objective: To estimate the prevalence of cognitive impairment in a diverse Parkinson’s disease (PD) cohort and explore its associations with vascular, motor, and non-motor determinants.…
  • 2026 International Congress

    A novel pro-drug overcomes short-half life and absorption challenges and increase brain penetration of dopamine as a potential therapy for Parkinson’s disease

    C. Moussa (Washington DC, USA)

    Objective: We developed a new small molecule drug candidate that would increase the effectiveness of dopamine delivery to the brain. We also sought to mitigate…
  • 2026 International Congress

    Cortical–Subcortical Structural Signature of dementia with lewy bodies Reveals Cognitive Trajectories of Lewy Body Disease in REM Sleep Behavior Disorder

    JH. Shin, HJ. Kim, JY. Lee (Seoul, Democratic People's Republic of Korea)

    Objective: We aimed to derive a DLB-related structural MRI pattern based on cortical and subcortical morphometry and investigate whether this pattern predicts phenoconversion and clinical…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 25
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley